Does a Little Difference Make a Big Difference? Bovine β-Casein A1 and A2 Variants and Human Health—An Update
For over 20 years, bovine beta-casein has been a subject of increasing scientific interest because its genetic A1 variant during gastrointestinal digestion releases opioid-like peptide β-casomorphin-7 (β-CM-7). Since β-CM-7 is involved in the dysregulation of many physiological processes, there is a...
Main Authors: | Anna Cieślińska, Ewa Fiedorowicz, Dominika Rozmus, Edyta Sienkiewicz-Szłapka, Beata Jarmołowska, Stanisław Kamiński |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/15637 |
Similar Items
-
Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants—A Review
by: Marta Liliane de Vasconcelos, et al.
Published: (2023-08-01) -
Identification of Polymorphisms of the <i>CSN2</i> Gene Encoding β-Casein in Greek Local Breeds of Cattle
by: Dionysios Antonopoulos, et al.
Published: (2021-10-01) -
Changes in Metabolites from Bovine Milk with β-Casein Variants Revealed by Metabolomics
by: Zhongwang Lv, et al.
Published: (2020-05-01) -
Worldwide research on the health effects of bovine milk containing A1 and A2 β-casein: Unraveling the current scenario and future trends through bibliometrics and text mining
by: Jhony Alberto Gonzales-Malca, et al.
Published: (2023-01-01) -
A2 Milk: New Perspectives for Food Technology and Human Health
by: Salvador Fernández-Rico, et al.
Published: (2022-08-01)